Form 4: Healthstream Director Linda Rebrovick Granted 3,048 Restricted Share Units

Healthstream Inc. Director Linda Rebrovick was granted 3,048 Restricted Share Units (RSUs) as part of her compensation, aligning her interests with shareholders.

Summary

• Linda Rebrovick, a Director of Healthstream Inc. (HSTM), was granted 3,048 Restricted Share Units (RSUs) on May 29, 2025.
• Each RSU represents the contingent right to receive one share of common stock upon vesting of the unit.
• The RSUs are subject to a three-year vesting schedule, contingent upon Ms. Rebrovick's continued service at the time of vesting.
• Vesting will occur annually in three equal installments, with the first installment beginning on May 29, 2026.
• Following this reported transaction, Ms. Rebrovick directly beneficially owns 56,049 shares of common stock and 3,048 Restricted Share Units.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive sign as it aligns their interests with shareholders, promoting long-term value creation. It's a routine compensation event, not indicative of major operational changes.

Positives

• The grant of Restricted Share Units (RSUs) to Director Linda Rebrovick aligns her long-term interests with those of Healthstream Inc. shareholders.
• Equity-based compensation is a common and effective method to incentivize directors to contribute to the company's sustained growth and performance.

Negatives

• No negative aspects are indicated in this routine insider compensation filing.

Risks

• No specific risks are detailed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

The Restricted Share Units granted to Director Linda Rebrovick are scheduled to vest annually in three equal installments, beginning May 29, 2026, contingent upon her continued service to the company.

Industry Context

The grant of Restricted Share Units to a director is a standard practice in corporate governance across various industries, including healthcare technology, to attract and retain qualified board members and align their incentives with long-term shareholder value.

Comparison to Industry Standards

• Equity compensation, such as Restricted Share Units (RSUs), is a widely adopted practice for non-employee directors in publicly traded companies, including those in the healthcare technology sector like Healthstream Inc.
• The three-year vesting schedule is a common structure designed to promote long-term commitment and performance, comparable to similar arrangements seen at companies like Veeva Systems (VEEV) or Cerner (now Oracle Health).
• The grant of RSUs at a $0 exercise price is typical for such awards, reflecting their nature as a direct equity grant rather than an option.

Corporate Governance

Related Party Transactions

• The grant of Restricted Share Units to a director constitutes a related party transaction, as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director's interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Continued service of Director Linda Rebrovick to facilitate the vesting of her Restricted Share Units.
• Annual vesting of 1,016 RSUs on May 29, 2026, and subsequent anniversaries for two more years.

Key Dates

Keywords

Healthstream, HSTM, SEC Form 4, Director Compensation, Restricted Share Units, RSU, Equity Grant, Insider Transaction, Corporate Governance